Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
AstraZeneca’s senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.
AstraZeneca is hopping aboard the pickleball craze as its serves up a new marketing push for its asthma med Fasenra. | ...
1h
E! Online on MSNErin Andrews Reveals How Cancer Continues to Affect Her LifeNearly a decade after Erin Andrews was diagnosed with cervical cancer, the sportscaster told E! News she can't treat ...
3h
Investor's Business Daily on MSNAstraZeneca ADR Scores Relative Strength Rating Upgrade; Hits Key ThresholdAstraZeneca ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.
The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the ...
In 2025, Cellectis will continue to focus its efforts and expenses on advancing its core clinical trials BALLI-01 and NATHALI ...
STORY: Stubborn inflation and President Donald Trump’s trade policies have rekindled fears of stagflation, a troubling ...
A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...
23h
MedPage Today on MSNNCI Flags 'Cancer Moonshot'; Dr. Hologram Will See You; Fraud Crackdown ContinuesThe American Cancer Society awarded its 2025 Medal of Honor to W. Kimryn Rathmell, MD, PhD, renowned kidney cancer expert and ...
1h
The Citizen on MSNAnalysis-As Trump thaws ties, Russia has a new public enemy number one: BritainTwo British diplomats expelled in a spying row. A blistering statement from Russia's foreign intelligence service calling ...
She would have explained that there had been 14 documented deaths linked with Covid vaccines across Australia, where more than 60 million doses have been administered. Thirteen of those deaths were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results